PharmaCielo Ltd.
PCLOF
$0.07
$0.0250.93%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 18.84% | -32.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.84% | -32.64% | |||
| Cost of Revenue | 210.87% | -128.35% | |||
| Gross Profit | -72.15% | 299.67% | |||
| SG&A Expenses | 112.84% | -85.22% | |||
| Depreciation & Amortization | 96.55% | -91.78% | |||
| Other Operating Expenses | 208.37% | -1,857.49% | |||
| Total Operating Expenses | 315.62% | -127.47% | |||
| Operating Income | -188.10% | 159.31% | |||
| Income Before Tax | -419.47% | 129.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -419.47% | 129.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -419.47% | 129.04% | |||
| EBIT | -188.10% | 159.31% | |||
| EBITDA | -126.50% | 178.17% | |||
| EPS Basic | -406.25% | 129.63% | |||
| Normalized Basic EPS | -320.00% | 109.62% | |||
| EPS Diluted | -406.25% | 129.63% | |||
| Normalized Diluted EPS | -320.00% | 109.62% | |||
| Average Basic Shares Outstanding | 1.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.06% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||